Welcome back, everyone. We hope your weekend was splendid and you had a chance to recharge. The weather, after all, was magnificent. Now, of course, the time has come to return to the routine. So as you brace for those meetings and deadlines, please join us as we reach for our treasured cup of stimulation and dig in for another day. Hope yours goes well. And do stay in touch...
Glaxo Will Not Bid For Genzyme (Reuters)
The Problem With Gardasil (Fortune)
A Painful Summer For J&J CEO Bill Weldon (Fortune)
Actus And Sequoia To Sell Stake In Paras (Bloomberg News)
Genzyme Job Cuts To Follow Takeover (The Boston Globe)
AstraZeneca Signs Emerging Markets Deal With Aurobindo (PharmaTimes)